Eve continues to execute! "With this approval, we intend to ramp-up production over the next two quarters which will give us the ability to become a significant supplier to the Canadian and global cannabis markets(1),” said Melinda Rombouts, President and CEO of Eve & Co.
Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce that Health Canada has approved an amendment to the licence of its wholly-owned subsidiary, Natural MedCo Ltd., permitting the use of a 7,300 square foot area (“Processing Area 2“) as eleven additional processing rooms. Processing Area 2 enables the Company to continue its production ramp-up to supply cannabis markets in Canada and abroad under its European Union Certificate of Good Manufacturing Practice from the Government of Upper Bavaria, Germany.
